Applications of process analytical technology to crystallization processes

Advanced Drug Delivery Reviews

Volumn 56, Issue 3, 2004, Pages 349-369

  Yu, Lawrence X ^a   Lionberger, Robert A ^a   Raw, Andre S ^a   D'Costa, Rosario ^a   Wu, Huiquan ^a   Hussain, Ajaz S ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Control; Crystallization; In situ; Modelling; Polymorphism; Process analytical technology; Simulation

Indexed keywords

COMPUTER SIMULATION; CRYSTALLIZATION; DRUG PRODUCTS PLANTS; OPTIMIZATION; RAW MATERIALS;

CHEMOMETRICS; PHARMACEUTICAL INDUSTRY;

DRUG PRODUCTS;

DRUG ADDITIVE; GLUTAMIC ACID; GLYCINE; PROGESTERONE; RITONAVIR; SODIUM CHLORATE; SODIUM DITHIONITE; TROVAFLOXACIN;

CHEMOMETRICS; CRYSTAL STRUCTURE; CRYSTALLIZATION; DATA ANALYSIS; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DOSAGE FORM; DRUG INDUSTRY; DRUG MONITORING; FEEDBACK SYSTEM; FOOD AND DRUG ADMINISTRATION; INFRARED SPECTROSCOPY; MICROSCOPY; MOLECULAR MODEL; MULTIVARIATE ANALYSIS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PARTICLE SIZE; PRIORITY JOURNAL; PROCESS TECHNOLOGY; RAMAN SPECTROMETRY; REVIEW; SENSOR; SIMULATION; SOLID STATE; THERMAL ANALYSIS; THERMOGRAVIMETRY; X RAY DIFFRACTION; X RAY POWDER DIFFRACTION;

EID: 1042264120     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addr.2003.10.012     Document Type: Article

References (51)

1. FDA, FDA PAT page. URL http://www.fda.gov/cder/OPS/PAT.htm.
2. Mohan R., Myerson A.S. Growth kinetics: a thermodynamic approach. Chem. Eng. Sci. 57:2002;4277-4285.
3. Gu C.H., Young V.J., Grant D.J. Polymorph screening: influence of solvents on the rate of solvent-mediated polymorphic transformation. J. Pharm. Sci. 90:2001;1878-1890.
4. Winn D., Doherty M.F. Modeling crystal shapes of organic materials grown from solution. AIChE J. 46:2000;1349-1367.
5. Ma D.L., Tafti D.K., Braatz R.D. Optimal control and simulation of multidimensional crystallization. Comp. Chem. Eng. 26:2002;1103-1116.
6. Bugay D.E. Characterization of the solid-state: spectroscopic techniques. Adv. Drug Deliv. Rev. 48:2001;43-65.
7. Stephenson G.A., Forbes R.A., Reutzel-Edens S.M. Characterization of the solid state: quantitative issues. Adv. Drug Deliv. Rev. 48:2001;67-90.
8. Kueppers S., Haider M. Process analytical chemistry - future trends in industry. Anal. Bioanal. Chem. 376:2003;313-315.
9. Workman J.J., Creasy K.E., Doherty S., Bond L., Koch M., Ullman A., Veltkamp D.J. Process analytical chemistry. Anal. Chem. 73:2001;2705-2718.
10. Salari A., Young R.E. Application of attenuated total reflectance FTIR spectroscopy to the analysis of mixtures of pharmaceutical polymorphs. Int. J. Pharm. 163:1998;157-166.
11. Helmy R., Zhou G.X., Chen Y.W., Crocker L., Wang T., Wenslow R.M.J., Vailaya A. Characterization and quantitation of aprepitant drug substance polymorphs by attenuated total reflectance Fourier transform infrared spectroscopy. Anal. Chem. 75:2003;605-611.
12. Togkalidou T., Fujiwara M., Patel S., Braatz R.D. Solute concentration prediction using chemometrics and ATR-FTIR spectroscopy. J. Cryst. Growth. 231:2001;534-543.
13. Fevotte G. New perspectives for the on-line monitoring of pharmaceutical crystallization processes using in situ infrared spectroscopy. Int. J. Pharm. 241:2002;263-278.
14. Togkalidou T., Tung H.-H., Sun Y., Andrews A., Braatz R.D. Solution concentration prediction for pharmaceutical crystallization processes using robust chemometrics and ATR FTIR spectroscopy. Org. Process Res. Dev. 6:2002;317-322.
15. Ham F.M., Kostanic I.N., Cohen G.M., Gooch B.R. Determination of glucose concentrations in an aqueous matrix from NIR spectra using optimal time-domain filtering and partial least-squares regression. IEEE Trans. Biomed. Eng. 44:1997;475-485.
16. Scheffold F. Particle sizing with diffusing wave spectroscopy. J. Disp. Sci. Tech. 23:2002;591-599.
17. Quesada-Perez M., Callejas-Fernandez J., Hidalgo-Alvarez R. Probing electrostatic forces in colloidal suspensions through turbidity data. J. Colloid Interf. Sci. 217:1999;177-185.
18. Balgi G., Reynolds J., Mayer R.H., Cooley R.E., Sevick-Muraca E.M. Measurements of multiply scattered light for on-line monitoring of changes in size distribution of cell debris suspension. Biotechnol. Prog. 15:1999;1106-1114.
19. Urban C., Schurtenberger P. Characterization of turbid colloidal suspensions using light scattering techniques combined with cross-correlation methods. J. Colloid Interf. Sci. 207:1998;150-158.
20. Lasentec, Lasentec home page. URL http://www.lasentec.com.
21. Mougin P., Wilkinson D. In situ measurement of particle size during the crystallization of L-glutamic acid under two polymorphic forms: influence of crystal habit on ultrasonic attenuation measurements. Cryst. Growth Des. 2:2002;227-234.
22. Dukhin A.S., Goetz P.J. Acoustic and electroacoustic spectroscopy for characterizing concentrated dispersions and emulsions. Adv. Colloid Interf. Sci. 92:2001;73-132.
23. Higgins J.P., Arrivo S.M., Thurau G., Green R.L., Bowen W., Lange A., Templeton A.C., Thomas D.L., Reed R.A. Spectroscopic approach for on-line monitoring of particle size during the processing of pharmaceutical nanoparticles. Anal. Chem. 75:2003;1777-1785.
24. Anquetil P.A., Brenan C.J.H., Marcolli C., Hunter I.W. Laser Raman spectroscopic analysis of polymorphic forms in microliter fluid volumes. J. Pharm. Sci. 92:(1):2003;149-160.
25. Vrcelj R.M., Gallagher H.G., Sherwood J.N. Polymorphism in 2,4,6-trinitrotoluene crystallized from solution. J. Am. Chem. Soc. 123:2001;2291-2295.
26. Blagden N., Davey R., Song M., Quayle M., Clark S., Taylor D., Nield A. A novel batch cooling crystallizer for in situ monitoring of solution crystallization using energy dispersive X-ray diffraction. Cryst. Growth Des. 3:2003;197-201.
27. Bede, Bede home page. URL http://www.bede.co.uk .
28. Norris T., Aldridge P.K., Sekulic S.S. Determination of end-points for polymorph conversions of crystalline organic compounds using on-line near-infrared spectroscopy. Analyst. 122:1997;549-552.
29. Morari M., Zafiriou E. Robust Process Control. 1989;Prentice-Hall, Englewood Cliffs.
30. Kourti T., MacGregor J. Multivariate SPC methods for process and product monitoring. J. Qual. Tech. 28:1996;409-428.
31. Boque R., Smilde A. Monitoring and diagnosing batch processes with multiway regression models. AIChE J. 45:1999;1504-1520.
32. Beckmann W. Seeding the desired polymorph: background, possibilities, limitations, and case studies. Org. Process Res. Dev. 4:2000;372-383.
33. Rawlings J.B., Miller S.M., Witkowski W.R. Model identification and control of solution crystallization processes: a review. IEC Res. 32:1993;1275-1296.
34. Brereton R. Multivariate Pattern Recognition in Chemometrics. 1992;Elsievier, Amsterdam.
35. Brown S.D., Bear R., Blank T. Chemometrics. Anal. Chem. 64:1992;22R-49R.
36. Wold S., Kettaneh-Wold N., Skagerberg B. Nonlinear PLS modelling. Chemometr. Intell. Lab. Syst. 7:1989;53-65.
37. Taavitsainen V., Korhonen P. Nonlinear data analysis with latent variables. Chemometr. Intell. Lab. Syst. 14:1992;185-194.
38. Gabrielsson J., Lindberg N., Lundstedt T. Multivariate methods in pharmaceutical applications. J. Chemometr. 16:2002;141-160.
39. Togkalidoua T., Braatz R.D., Johnson B.K., Davidsonc O., Andrews A. Experimental design and inferential modeling in pharmaceutical crystallization. AIChE J. 47:2001;160-168.
40. Chemburkar S.R., Bauer J., Deming K., Spiwek H., Patel K., Morris J., Henry R., Spanton S., Dziki W., Porter W., Quick J., Bauer P., Donaubauer J., Narayanan B.A., Soldani M., Riley D., McFarland K. Dealing with the impact of ritonavir polymorphs on the late stages of bulk drug process development. Org. Process Res. Dev. 4:2000;413-417.
41. Morissette S.L., Soukasene S., Levinson D., Cima M.J., Almarsson O. Elucidation of crystal form diversity of the HIV protease inhibitor ritonavir by high-throughput crystallization. Proc. Natl. Acad. Sci. USA. 100:2003;2180-2184.
42. Pratiwi D., Fawcett J.P., Gordon K.C., Rades T. Quantitative analysis of polymorphic mixtures of ranitidine hydrochloride by Raman spectroscopy and principal components analysis. Eur. J. Pharm. Biopharm. 54:2002;337-341.
43. Matthews H., Rawlings J. Batch crystallization of a photochemical: modeling, control, and filtration. AIChE J. 44:1998;1119-1127.
44. H.B. Matthews, Model identification and control of batch crystallization for an industrial chemical system, Ph.D. Thesis, University of Wisconsin, (1997).
45. Fujiwara M., Chow P.S., Ma D.L., Braatz R.D. Paracetamol crystallization using laser backscattering and ATR-FTIR spectroscopy: metastability, agglomeration, and control. Cryst. Growth Des. 2:2002;363-370.
46. Ristic R., Sherwood J.N., Wojciechowski K. Morphology and growth kinetics of large sodium chlorate crystals grown in the presence and absence of sodium dithionate impurity. J. Phys. Chem. 97:1993;10774-10782.
47. Ristic R., Shekunov B.Y., Sherwood J.N. Growth of the tetrahedral faces of sodium chlorate crystals in the presence of dithionate impurity. J. Cryst. Growth. 139:1994;336-343.
48. D.B. Patience, Crystal engineering through particle size and shape monitoring, modeling, and control, Ph.D. Thesis, University of Wisconsin, (2002).
49. Patience D.B., Rawlings J.B. Particle-shape monitoring and control in crystallization processes. AIChE J. 47:2001;2125-2130.
50. Wang F., Wachter J.A., Antosz F.J., Berglund K.A. An investigation of solvent-mediated polymorphic transformation of progesterone using in situ Raman spectroscopy. Org. Process Res. Dev. 4:2000;391-395.
51. Starbuck C., Spartalis A., Wai L., Wang J., Fernandez P., Lindemann C.M., Zhou G.X., Ge Z. Process optimization of a complex pharmaceutical polymorphic system via in situ Raman spectroscopy. Cryst. Growth Des. 2:2002;515-522.